BostonGene
BostonGene Corporation is a precision medicine company advancing cancer treatment through AI-powered molecular and immune profiling. Their cloud-based platform integrates multiomic analytics, bioinformatics, and next-generation sequencing to provide comprehensive tumor, microenvironment, and host immunity analysis. BostonGene supports healthcare providers, pharmaceutical, and biotech companies by enabling personalized therapy decisions, accelerating drug development, and improving patient outcomes. Their key products include the BostonGene Tumor Portrait™ test, Liquid Biopsy, Immune System Profiling, and various AI-driven tools for biomarker discovery, clinical trial support, and drug repurposing. The company collaborates with leading cancer centers and pharmaceutical companies such as Johnson & Johnson, Takeda, BeiGene, and MD Anderson Cancer Center, positioning itself as a leader in precision oncology diagnostics and therapeutics.
BostonGene
BostonGene Corporation is a precision medicine company advancing cancer treatment through AI-powered molecular and immune profiling. Their cloud-based platform integrates multiomic analytics, bioinformatics, and next-generation sequencing to provide comprehensive tumor, microenvironment, and host immunity analysis. BostonGene supports healthcare providers, pharmaceutical, and biotech companies by enabling personalized therapy decisions, accelerating drug development, and improving patient outcomes. Their key products include the BostonGene Tumor Portrait™ test, Liquid Biopsy, Immune System Profiling, and various AI-driven tools for biomarker discovery, clinical trial support, and drug repurposing. The company collaborates with leading cancer centers and pharmaceutical companies such as Johnson & Johnson, Takeda, BeiGene, and MD Anderson Cancer Center, positioning itself as a leader in precision oncology diagnostics and therapeutics.